Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22194472 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Vandetanib in Advanced NSCLC With RET Rearrangement
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Vandetanib

Indicates status has not been verified in more than two years